Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.90 |
| ▸ | FAAH | O00519 | 4/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.74 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.74 |
| ▸ | MEN1 | O00255 | 1/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.74 |
| ▸ | LMNA | P02545 | 1/20 | 0.74 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.64 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.64 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.64 |
| ▸ | PRKCA | P17252 | 1/20 | 0.64 |
| ▸ | LPAR1 | Q92633 | 7/20 | 0.64 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.64 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.64 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.64 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.64 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.64 |
| ▸ | CES2 | O00748 | 1/20 | 0.64 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.64 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glyceryl Monooleate SCHEMBL3025522 | 0.97 | DGKA (0.85) | DGKAFAAHKDM4EDUSP3MEN1 | |
| Glyceryl Monooleate SCHEMBL5608924 | 0.95 | DGKA (0.90) | DGKAFAAHKDM4EDUSP3MEN1 | |
| Glyceryl Monooleate SCHEMBL15604 | 0.95 | DGKA (1.00) | DGKAFAAHKDM4EDUSP3MEN1 | |
| Glyceryl Monooleate SCHEMBL4398941 | 0.95 | DGKA (1.00) | DGKAFAAHKDM4EDUSP3MEN1 | |
| Glyceryl Monooleate SCHEMBL4065294 | 0.95 | DGKA (1.00) | DGKAFAAHKDM4EDUSP3MEN1 | |
| SCHEMBL5158478 | 0.95 | DGKA (1.00) | DGKAFAAHKDM4EDUSP3MEN1 | |
| SCHEMBL18970879 | 0.95 | DGKA (1.00) | DGKAFAAHKDM4EDUSP3MEN1 | |
| SCHEMBL20719744 | 0.95 | DGKA (1.00) | DGKAFAAHKDM4EDUSP3MEN1 | |
| SCHEMBL20719833 | 0.95 | DGKA (1.00) | DGKAFAAHKDM4EDUSP3MEN1 | |
| SCHEMBL20719803 | 0.95 | DGKA (1.00) | DGKAFAAHKDM4EDUSP3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200390785-A1 | Liver Disease | LIPOCINE INC. (US) | 2020-12-17 | — | — | US | claimed |
| US-20200383998-A1 | Liver Disease | LIPOCINE INC. (US) | 2020-12-10 | — | — | US | claimed |
| US-20060148877-A1 | Pharmaceutical formulations of celcoxib | TRANSFORM PHARMACEUTICALS, INC. (US) | 2006-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060148877-A1 | Pharmaceutical formulations of celcoxib | CBX2, CBX3, LPXN | DGKA 4724/4885FAAH 939/4885KDM4E 625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.